Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep;10(3):221-227.
doi: 10.1055/s-0040-1713144. Epub 2020 Jun 10.

Extended Duration Ketamine Infusions in Critically Ill Children: A Case Report and Review of the Literature

Eszter Moore  1 , Rebecca Mayes  1 , Maura Harkin  1   2 , Jamie L Miller  1   2 , Peter N Johnson  1   2
Affiliations
Case Reports

Extended Duration Ketamine Infusions in Critically Ill Children: A Case Report and Review of the Literature

Eszter Moore et al. J Pediatr Intensive Care. 2021 Sep.

Abstract

Ketamine is an N -methyl-D-aspartate receptor antagonist that has been used as an adjunct analgesic and sedative in critically ill children. Previous reports noted that ketamine has been used for a variable duration of 12 to 408 hours for this indication. We report on the use of ketamine infusions for >720 hours as a second-line sedative in addition to an opioid and dexmedetomidine infusion in a 2-month old and 17-month old. The purpose of this case report and review of the literature is to highlight the prolonged ketamine exposure of these two patients and to provide awareness to clinicians on the potential of withdrawal with extended ketamine administration. These children were started on initials doses of 5 and 15 µg/kg/min and titrated to peak doses of 20 and 25 µg/kg/min, respectively. They were continued for a total of 987 and 792 hours, respectively. No adverse events were noted during the ketamine infusions. One patient developed possible withdrawal symptoms 17 hours after ketamine discontinuation despite tapering of the infusion. These symptoms resolved with administration of as needed intravenous opioids and benzodiazepines, and the agitation normalized within 24 hours after ketamine discontinuation. Clinicians should consider tapering ketamine infusions in children receiving >72 hours of a continuous infusion by 5 µg/kg/min every 8 to 12 hours. Patients should be monitored for potential withdrawal symptoms including anxiety, allodynia, hyperalgesia, sweating, and drowsiness.

Keywords: children; ketamine; withdrawal.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

Figures

Fig. 1
Fig. 1
Patient 1 sedation and analgesia flow diagram.
Fig. 2
Fig. 2
Patient 2 sedation and analgesia flow diagram.
See this image and copyright information in PMC

References

    1. Golding C L, Miller J L, Gessouroun M R, Johnson P N. Ketamine continuous infusions in critically ill infants and children. Ann Pharmacother. 2016;50(03):234–241. - PubMed
    1. Mion G, Villevieille T. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings) CNS Neurosci Ther. 2013;19(06):370–380. - PMC - PubMed
    1. Heiberger A L, Ngorsuraches S, Olgun G et al.Safety and utility of continuous ketamine infusion for sedation in mechanically ventilated pediatric patients. J Pediatr Pharmacol Ther. 2018;23(06):447–454. - PMC - PubMed
    1. Neunhoeffer F, Hanser A, Esslinger M et al.Ketamine infusion as a counter measure for opioid tolerance in mechanically ventilated children: a pilot study. Paediatr Drugs. 2017;19(03):259–265. - PubMed
    1. Tobias J D, Martin L D, Wetzel R C. Ketamine by continuous infusion for sedation in the pediatric intensive care unit. Crit Care Med. 1990;18(08):819–821. - PubMed

Publication types